Pamela Ann Connealy - 25 Sep 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role: CFO and COO
Signature: /s/ Pamela Connealy
Issuer symbol: PYXS
Transactions as of: 25 Sep 2023
Net transactions value: +$20,044
Form type: 4
Filing time: 25 Sep 2023, 17:04:12 UTC
Previous filing: 22 Sep 2023
Next filing: 27 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PYXS	Common Stock	Purchase	$20,044	+12,000	+1.5%	$1.67	804,106	25 Sep 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average purchase price of common stock purchased by the Reporting Person in open market transactions. The range of purchase prices on the transaction date was $1.615 to $1.70 per share. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each price.

Content

Represents the weighted average purchase price of common stock purchased by the Reporting Person in open market transactions. The range of purchase prices on the transaction date was $1.615 to $1.70 per share. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each price.